Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study

Messoud Ashina*, David Dodick, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, Feng Zhang, Julia R. Gage, Sunfa Cheng, Daniel D. Mikol, Robert A. Lenz

*Corresponding author af dette arbejde
86 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science